Thoma Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794K Buy
2,193
+27
+1% +$9.24K 0.42% 32
2026
Q1
$762K Buy
2,166
+51
+2% +$18.2K 0.45% 35
2025
Q4
$692K Sell
2,115
-179
-8% -$56.8K 0.4% 42
2025
Q3
$647K Sell
2,294
-223
-9% -$64.7K 0.37% 43
2025
Q2
$703K Buy
2,517
+35
+1% +$9.91K 0.45% 36
2025
Q1
$773K Sell
2,482
-139
-5% -$41K 0.54% 28
2024
Q4
$683K Buy
+2,621
New +$778K 0.47% 37

Other funds holding AMGN

Thoma Capital Management's AMGN Position: Q2 2026 in Review

Thoma Capital Management increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $9.24K and bringing the position to 2,193 shares worth $794K. The position accounts for 0.42% of the portfolio, ranked #32.

Thoma Capital Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Thoma Capital Management held 2,193 shares of Amgen worth $794K as of Q2 2026.
  • Thoma Capital Management bought 27 Amgen shares in Q2 2026, an estimated $9.24K.
  • Amgen made up 0.42% of Thoma Capital Management's portfolio in Q2 2026, its #32 holding.
  • Thoma Capital Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Thoma Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.